Allgens Medical Technology CO., LTD. (SHA:688613)

SHA:688613 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	98.69	169.07	156.71	161.25	259.87	411.31
Short-Term Investments	-	-	-	27.74	-	-
Trading Asset Securities	913.5	913.63	895.57	902.18	816.08	653.88
Cash & Short-Term Investments	1,012	1,083	1,052	1,091	1,076	1,065
Cash Growth	-4.23%	2.89%	-3.56%	1.42%	1.01%	116.58%
Accounts Receivable	50.8	27.46	67.16	59.27	38.88	27.85
Other Receivables	24.22	14.83	13.75	9.47	1.04	4.05
Receivables	75.02	42.29	80.91	68.74	39.92	31.9
Inventory	76.19	76.94	54.58	32.7	18.31	19.03
Prepaid Expenses	0.33	-	-	-	0.1	0.66
Other Current Assets	28.62	21.61	8.62	8.13	8.06	4.11
Total Current Assets	1,192	1,224	1,196	1,201	1,142	1,121
Property, Plant & Equipment	179.12	178.04	180.57	186.57	188.82	195.53
Goodwill	24.62	24.62	24.62	-	-	-
Other Intangible Assets	22.97	23.76	25.36	22.06	23.36	24.63
Long-Term Deferred Tax Assets	23.43	23.43	23.84	21.73	18.59	14.18
Long-Term Deferred Charges	27.43	30.49	35.49	34.66	21.64	4.32
Other Long-Term Assets	51.55	60	52.88	60.49	64.45	66.54
Total Assets	1,521	1,564	1,539	1,526	1,459	1,426

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.47	12.41	12.95	10.39	7.38	3.3
Accrued Expenses	8.73	25.37	19.18	12.96	12.57	17.52
Current Portion of Long-Term Debt	2.8	34.16	4.6	4.1	10.67	8.68
Current Portion of Leases	2.91	2.74	2.02	0.97	5.01	10.44
Current Income Taxes Payable	0	0.13	4.44	-	2.72	1.18
Current Unearned Revenue	5.43	5.66	5.11	10.23	4.02	2.94
Other Current Liabilities	1.26	1.52	3.97	12.15	6.09	11.12
Total Current Liabilities	26.6	81.98	52.26	50.79	48.46	55.18
Long-Term Debt	20	6.5	40.75	45.35	45.9	56.5
Long-Term Leases	3.82	4.53	4.98	3	-	5.01
Long-Term Unearned Revenue	19.55	19.97	20.94	22.19	34.94	36.19
Long-Term Deferred Tax Liabilities	3.53	3.54	0.26	1.28	4.2	2.61
Total Liabilities	73.49	116.52	119.2	122.61	133.5	155.49

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	137.01	137.01	135.55	133.33	133.33	133.33
Additional Paid-In Capital	982.58	982.58	966.59	926.92	887.73	887.73
Retained Earnings	317.62	314.87	301.03	321.82	281.63	222.68
Comprehensive Income & Other	-0.41	0.15	-0.29	-	0.23	0.53
Total Common Equity	1,437	1,435	1,403	1,382	1,303	1,244
Minority Interest	11.17	12.75	17.09	21.57	22.79	26.31
Shareholders' Equity	1,448	1,447	1,420	1,404	1,326	1,271
Total Liabilities & Equity	1,521	1,564	1,539	1,526	1,459	1,426

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	29.52	47.93	52.35	53.42	61.59	80.63
Net Cash (Debt)	982.67	1,035	999.93	1,038	1,014	984.56
Net Cash Growth	-2.73%	3.48%	-3.65%	2.31%	3.03%	133.12%
Net Cash Per Share	6.98	7.48	7.11	7.85	7.56	8.23
Filing Date Shares Outstanding	137.01	137.01	135.55	133.33	133.33	133.33
Total Common Shares Outstanding	137.01	137.01	135.55	133.33	133.33	133.33
Working Capital	1,166	1,142	1,144	1,150	1,094	1,066
Book Value Per Share	10.49	10.47	10.35	10.37	9.77	9.33
Tangible Book Value	1,389	1,386	1,353	1,360	1,280	1,220
Tangible Book Value Per Share	10.14	10.12	9.98	10.20	9.60	9.15
Buildings	191.66	191.66	190.14	187.21	185.69	117.45
Machinery	72.7	67.2	63.64	60.14	31.14	32.26
Construction In Progress	11.59	7.35	0.07	0.33	1.47	60.85

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 25, 2026

Data Sources Report a data error